 NEW YORK, Nov. 25, 2020 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. Sonoma or the Company NASDAQ: SNOA. Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 7980... 